KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Change in Inventory (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Change in Inventory for 16 consecutive years, with $2.3 million as the latest value for Q4 2025.

Quarterly Change in Inventory rose 73.57% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 262.36% year-over-year, with the annual reading at $1.3 million for FY2025, 262.36% up from the prior year.
Change in Inventory for Q4 2025 was $2.3 million at Biolife Solutions, up from $197000.0 in the prior quarter.
The five-year high for Change in Inventory was $6.4 million in Q1 2023, with the low at -$2.2 million in Q2 2023.
Average Change in Inventory over 5 years is $774200.0, with a median of $192000.0 recorded in 2025.
The sharpest move saw Change in Inventory skyrocketed 2753.85% in 2022, then plummeted 3345.24% in 2025.
Over 5 years, Change in Inventory stood at -$1.4 million in 2021, then skyrocketed by 185.57% to $1.2 million in 2022, then crashed by 91.18% to $102000.0 in 2023, then surged by 1216.67% to $1.3 million in 2024, then surged by 73.57% to $2.3 million in 2025.
According to Business Quant data, Change in Inventory over the past three periods came in at $2.3 million, $197000.0, and $187000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.